# Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus

> **NCT02842814** · NA · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 333 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **OTHER:** Drug free
- **DRUG:** HCQ
- **DRUG:** GC+HCQ

## Key facts

- **NCT ID:** NCT02842814
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2022-09-28
- **Final completion:** 2022-09-28
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2022-10-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02842814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02842814, "Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02842814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*